Analytical Data
-
Gene name
SMIM4
- Application
-
Alternative Names
/
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8WVI0
-
Expression Region
1-70aa
-
Molecular Weight
11.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SMIM4 (Small Integral Membrane Protein 4) is a newly identified protein that has garnered considerable interest in recent years due to its potential role in various physiological processes. Initially discovered through genomic studies, SMIM4 is thought to be involved in cellular signaling and membrane dynamics, which are crucial for numerous biological functions. Research indicates that SMIM4 may play a role in the regulation of hematopoiesis and immune responses, although its exact mechanisms remain poorly understood. The study of SMIM4 is significant not only for understanding its basic biology but also for exploring its implications in diseases, including hematological disorders and potential developmental anomalies. As a result, the expression and characterization of recombinant SMIM4 protein have become important in order to elucidate its structure, function, and interactions with other cellular components. This can pave the way for identifying novel therapeutic targets and strategies in treating related diseases. Furthermore, leveraging advanced techniques like site-directed mutagenesis and protein-protein interaction assays can provide deeper insights into the physiological role of SMIM4 and its potential as a biomarker in clinical settings. Overall, the exploration of SMIM4’s characteristics and functions represents a crucial step in expanding our understanding of integral membrane proteins and their broader implications in human health and disease.
